These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 2974348

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Effects of bezafibrate on lipoprotein lipids and apolipoproteins B and A1 in patients with primary hypercholesterolemia].
    Branchi A, Sommariva D, Tirrito M, Bonfiglioli D, Pini C, Scandiani L, Orlandi S, Fasoli A.
    Clin Ter; 1987 Jul 15; 122(1):17-23. PubMed ID: 2973892
    [No Abstract] [Full Text] [Related]

  • 3. [Effective long-term treatment of primary hyperlipoproteinemias with bezafibrate].
    Schiffl H, Weidmann P, Fragiacomo C, Noseda G, Bachmann C.
    Schweiz Med Wochenschr; 1985 Jun 29; 115(26):907-11. PubMed ID: 3927481
    [Abstract] [Full Text] [Related]

  • 4. [Effect of bezafibrate therapy on serum and lipoprotein lipids].
    Romics L, Németh Csóka M, Szám I, Pados G, Karádi I, Köszegi G, Kusztos R.
    Orv Hetil; 1986 Oct 05; 127(40):2425-8, 2431. PubMed ID: 3537905
    [No Abstract] [Full Text] [Related]

  • 5. Effects of CS-514, a new inhibitor of HMG CoA reductase, on plasma lipids, lipoproteins and apoproteins in patients with primary hypercholesterolemia.
    Kazumi T, Yoshino G, Kasama T, Iwatani I, Iwai M, Morita S, Baba S.
    Horm Metab Res; 1986 Sep 05; 18(9):654-5. PubMed ID: 3096862
    [No Abstract] [Full Text] [Related]

  • 6. Influence of bezafibrate and colestipol on LDL-cholesterol, LDL-apolipoprotein B and HDL-cholesterol in hyperlipoproteinaemia.
    Kłosiewicz-Latoszek L, Nowicka G, Szostak WB, Naruszewicz M.
    Atherosclerosis; 1987 Feb 05; 63(2-3):203-9. PubMed ID: 3827981
    [Abstract] [Full Text] [Related]

  • 7. [The therapeutic efficacy of bezafibrate in hyperlipoproteinemias of various types].
    Noseda G, Fragiacomo C, Weidmann P, Bachmann C.
    Schweiz Med Wochenschr; 1980 Dec 06; 110(49):1875-7. PubMed ID: 7455660
    [Abstract] [Full Text] [Related]

  • 8. Changes in the concentration and composition of lipids and lipoproteins in primary hyperlipoproteinemia during treatment with bezafibrate.
    Hutt V, Wechsler JG, Klör HU, Ditschuneit H.
    Arzneimittelforschung; 1983 Dec 06; 33(8):1185-90. PubMed ID: 6685498
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Type II hyperlipoproteinemia, hyperapobetalipoproteinemia, and hyperalphalipoproteinemia following renal transplantation: prevalence and precipitating factors.
    Lowry RP, Soltys G, Mangel R, Kwiterovitch P, Sniderman AD.
    Transplant Proc; 1987 Feb 06; 19(1 Pt 3):2229-32. PubMed ID: 3547921
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Sulfinpyrazone and lipoproteins: absence of effects on serum lipids in hyperlipoproteinemias of types II and IV].
    Sommariva D, Scotti L, Baroni L, Beggi P, Fasoli A.
    Clin Ter; 1980 Mar 31; 92(6):649-55. PubMed ID: 7460493
    [No Abstract] [Full Text] [Related]

  • 14. [Effect of bezafibrate on serum lipid, lipoprotein and apoprotein B levels in patients with type II and IV hyperlipoproteinemia].
    Sznajderman M.
    Pol Arch Med Wewn; 1983 Mar 31; 70(5-6):259-69. PubMed ID: 6677890
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of bezafibrate on the high-density lipoprotein subfractions HDL2 and HDL3 in primary hyperlipoproteinemia type IV.
    Schwandt P, Weisweiler P.
    Artery; 1980 Mar 31; 7(6):464-70. PubMed ID: 7236016
    [Abstract] [Full Text] [Related]

  • 18. [Plasma exchange therapy in a patient with familial hypercholesteremia and generalized arteriosclerosis].
    Schrecker O, Thies K, Schlierf G.
    Internist (Berl); 1984 Sep 31; 25(9):574-6. PubMed ID: 6386739
    [No Abstract] [Full Text] [Related]

  • 19. [Long-term oil therapy and lipid metabolism in peripheral arterial obstructive disease].
    Reuter W, Voigt H, Herrmann W, Köhler H, Peters HJ, Kuklinski B, Lindhofer HG, Hanf S.
    Z Gesamte Inn Med; 1985 Jun 01; 40(11):348-50. PubMed ID: 4036213
    [No Abstract] [Full Text] [Related]

  • 20. Acute lipidemic effect of calcium heparin in normolipemic and hyperlipemic subjects.
    Ferlito S, Ricceri M, Ossino AM.
    Int Angiol; 1989 Jun 01; 8(3):140-4. PubMed ID: 2592796
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.